Sara Blum Sherman

Investor Relations Contact bij EXSCIENTIA PLC

Health Technology

Technology Services

Profiel

Sara Blum Sherman is currently working as Vice President-Investor Relations at Exscientia AI Ltd. and Exscientia Plc.
She previously worked as Senior Director-Investor Relations & Strategy at DBV Technologies SA from 2016 to 2020 and as Head-Investor Relations at UroGen Pharma Ltd.

Actieve functies van Sara Blum Sherman

Bedrijven	Functie	Begin
EXSCIENTIA PLC	Investor Relations Contact	01-08-2021
Exscientia AI Ltd. Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services	Investor Relations Contact	-

Alle actieve functies van Sara Blum Sherman

Eerdere bekende functies van Sara Blum Sherman

Bedrijven	Functie	Einde
UROGEN PHARMA LTD.	Investor Relations Contact	01-08-2021
DBV TECHNOLOGIES	Public Communications Contact	01-09-2020

Ervaring van Sara Blum Sherman in detail bekijken

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van Sara Blum Sherman in detail bekijken

Connecties

Eerstegraads connecties

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Bedrijven in privébezit	4
DBV Technologies SA DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy	Health Technology
UroGen Pharma Ltd. UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies	Health Technology
Exscientia AI Ltd. Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Provides AI and machine learning techniques based drug discovery services	Health Technology
Exscientia Plc Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services	Technology Services